Valitor
Signal active
Organization
Contact Information
Overview
Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity. Their technology platform can be broadly applied to improve the pharmacological properties of many protein drugs that are currently approved or under development. They currently have three development pipelines in the fields of dermatology, ophthalmology, and orthopedics that highlight the capabilities of their novel drug products.
About
Industries
Developer Tools, Biotechnology, Medical, Therapeutics
Founded
2010
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Valitor headquartered in United States, North America, operates in the Developer Tools, Biotechnology, Medical, Therapeutics sector. The company focuses on Developer Tools and has secured $2.5B in funding across 64 round(s). With a team of 1-10 employees, Valitor is actively contributing to advancements in Developer Tools. Their latest funding round, Non Equity Assistance - Valitor, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
1
Lead Investors
0
Total Funding Amount
$39.0M
Details
2
Valitor has raised a total of $39.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Early Stage Venture | 2.5M | ||
| 2022 | Early Stage Venture | 28.0M |
Investors
Valitor is funded by 15 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Valitor | - | FUNDING ROUND - Valitor | 28.0M |
| First Spark Ventures | - | FUNDING ROUND - First Spark Ventures | 28.0M |
| Valitor | - | FUNDING ROUND - Valitor | undefined |
| SkyDeck Berkeley | - | FUNDING ROUND - SkyDeck Berkeley | undefined |
Recent Activity
There is no recent news or activity for this profile.